Effects of Replacement of Factor VIII Amino Acids Asp519 and Glu665 with Val on Plasma Survival and Efficacy In Vivo

Journal Title: The AAPS Journal - Year 2014, Vol 16, Issue 5

Abstract

Proteolytic cleavage of factor VIII (FVIII) to activated FVIIIa is required for participation in the coagulation cascade. The A2 domain is no longer covalently bound in the resulting activated heterotrimer and is highly unstable. Aspartic acid (D) 519 and glutamic acid (E) 665 at the A1–A2 and A2–A3 domain interfaces were identified as acidic residues in local hydrophobic pockets. Replacement with hydrophobic valine (V; D519V/E665V) improved the stability and activity of the mutant FVIII over the wild-type (WT) protein in several in vitro assays. In the current study, we examined the impact of mutations on secondary and tertiary structure as well as in vivo stability, pharmacokinetics (PK), efficacy, and immunogenicity in a murine model of Hemophilia A (HA). Biophysical characterization was performed with far-UV circular dichroism (CD) and fluorescence emission studies. PK and efficacy of FVIII was studied following i.v. bolus doses of 4, 10 and 40 IU/kg with chromogenic and tail clip assays. Immunogenicity was measured with the Bethesda assay and ELISA after a series of i.v. injections. Native secondary and tertiary structure was unaltered between variants. PK profiles were similar at higher doses, but at 4 IU/kg plasma survival of D519V/E665V was improved. Hemostasis at low concentrations was improved for the mutant. Immune response was similar between variants. Overall, these results demonstrate that stabilizing mutations in the A2 domain of FVIII can improve HA therapy in vivo.

Authors and Affiliations

Matthew P. Kosloski, Krithika A. Shetty, Hironao Wakabayashi, Philip J. Fay, Sathy V. Balu-Iyer

Keywords

Related Articles

Disposition of acetaminophen and indocyanine green in cystic fibrosis-knockout mice

Drug treatment poses a therapeutic challenge in cystic fibrosis (CF) because the disposition of a number of drugs is altered in CF. Enhanced clearance of acetaminophen (APAP) and indocyanine green (ICG) have previously b...

Synthesis and characterization of positively charged tPA as a prodrug using a heparin/protamine-based drug-delivery system

Positively charged peptides [(Arg)-Cys] were sucessfully linked to tissue-specific plasminogen activator (tPA) using cross-linking agent N-succinimidyl 3-(2-pyridyldithio) propionate. Specific amidolytic activity of this...

Variation of Stratum Corneum Biophysical and Molecular Properties with Anatomic Site

Several serine protease enzymes are known to be involved in both normal desquamation and the inflammatory processes of the skin. Alteration in the activity of these proteases should also affect corneocyte maturity and si...

Modeling Disease Progression in Acute Stroke Using Clinical Assessment Scales

The online version of this article (doi:10.1208/s12248-010-9230-0) contains supplementary material, which is available to authorized users.

Absorption Enhancers: Applications and Advances

Absorption enhancers are functional excipients included in formulations to improve the absorption of a pharmacologically active drug. The term absorption enhancer usually refers to an agent whose function is to increase...

Download PDF file
  • EP ID EP681670
  • DOI  10.1208/s12248-014-9627-2
  • Views 85
  • Downloads 0

How To Cite

Matthew P. Kosloski, Krithika A. Shetty, Hironao Wakabayashi, Philip J. Fay, Sathy V. Balu-Iyer (2014). Effects of Replacement of Factor VIII Amino Acids Asp519 and Glu665 with Val on Plasma Survival and Efficacy In Vivo. The AAPS Journal, 16(5), -. https://europub.co.uk/articles/-A-681670